MRI Superficial Temporal Artery

Temporal Arteritis Clinical Trial

Official title:

MRI of the Superficial Temporal Artery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00188448
• Other study ID #: 03-0223
• Status: Completed
• Phase: Phase 1
• First received: September 12, 2005
• Last updated: April 20, 2007
• Start date: April 2003
• Est. completion date: April 2004

Study information

• Verified date: September 2005
• Source: University Health Network, Toronto
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Interventional

Clinical Trial Summary

Repeat MRI of the Superficial temporal Artery in 5 volunteers

Description:

Repeat MRI of the Superficial temporal Artery in 5 volunteers

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5
• Est. completion date: April 2004
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• controls with normal temporal arteries

Exclusion Criteria:

• contraindication to MR

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Giant Cell Arteritis
• Temporal Arteritis

Intervention

Device:
• MRI

Locations

Country	Name	City	State
Canada	Toronto General Hospital	Toronto	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Accuracy in displaying the superfifical temporal artery